Explore top Series 65 exam prep courses to boost your career as an investment advisor. Access engaging materials and expert ...

MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The large series of programming changes will put some familiar faces in new ...

Add Yahoo as a preferred source to see more of our stories on Google. MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The ...

Cell phone bans in schools are working—at least as far as keeping kids off their phones during school, according to a new working paper. But the bans, which have been touted by researchers, educators ...

April 13 (Reuters) - Spyre Therapeutics (SYRE.O), opens new tab said on Monday its experimental drug showed a significant reduction in disease activity when tested in patients with ulcerative colitis ...

New qualitative research shows that students who were admitted through test-optional admissions generally don’t feel underqualified to attend their institutions, despite claims otherwise from those ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Researchers at ...

CU Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The ...

Elia projected, "On a projected basis, we anticipate suitable for robust assessment of VYD2311 effectiveness if the clinical performance of VYD2311 matches our modeling and prior experience with COVID ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...